.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
UBS
Deloitte
Cerilliant
Express Scripts
Teva
Covington
Queensland Health
Cantor Fitzgerald
Healthtrust

Generated: June 26, 2017

DrugPatentWatch Database Preview

Valproate sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for valproate sodium and what is the scope of valproate sodium patent protection?

Valproate sodium
is the generic ingredient in two branded drugs marketed by Hikma Farmaceutica, Fresenius Kabi Usa, Abbvie, and Athenex Inc, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for valproate sodium. Three suppliers are listed for this compound.

Summary for Generic Name: valproate sodium

Tradenames:2
Patents:1
Applicants:4
NDAs:4
Drug Master File Entries: see list9
Suppliers / Packagers: see list3
Bulk Api Vendors: see list131
Clinical Trials: see list2,471
Patent Applications: see list6,334
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:valproate sodium at DailyMed

Pharmacology for Ingredient: valproate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
DEPACON
valproate sodium
INJECTABLE;INJECTION020593-001Dec 30, 1996APRXYesYes► Subscribe► Subscribe
Hikma Farmaceutica
VALPROATE SODIUM
valproate sodium
INJECTABLE;INJECTION078523-001Feb 17, 2010APRXNoNo► Subscribe► Subscribe
Athenex Inc
VALPROATE SODIUM
valproate sodium
INJECTABLE;INJECTION076295-001Nov 14, 2002APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
VALPROATE SODIUM
valproate sodium
INJECTABLE;INJECTION076539-001Jun 26, 2003APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
AstraZeneca
Boehringer Ingelheim
QuintilesIMS
Farmers Insurance
UBS
US Army
Fish and Richardson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot